Mechanism

Facility access in this disclosure is governed by the biological identity architecture deployed as the primary mechanism for identity verification at a secure facility's entry boundary. Identity is not established by matching a presented credential or biometric sample against a stored template. It is established by trust-slope continuity validation: each biological observation of the individual is evaluated as a plausible successor to the prior sequence of observations in that individual's identity chain, and the identity resides in the continuity of the chain itself rather than in any enrolled profile. The question the system asks is not whether the presented sample matches an enrolled template, but whether the present sample is a plausible continuation of the signal trajectory established by the prior validated samples.

At each identity resolution event the architecture produces a biological hash: a non-invertible, domain-scoped, temporally bound representation of the individual's biological signal state at the time of the event. The biological hash is not compared against a stored template; it is evaluated for continuity with the sequence of prior biological hashes associated with the identity being validated. Because the hash is temporally bound, a stolen or replayed hash does not validate: continuity requires the next valid successor in the chain, not a repeat of a prior sample.

The biological identity substrate is one of three identity substrates in the platform, alongside device identity and agent identity, all sharing the architectural principle that identity is maintained through continuity validation rather than static credential presentation. For facility access the biological substrate may be compositionally bound to the others under policy, so that a high-assurance entry requires a biological identity presenting through a device with an attested device identity.

Tiered Acquisition at the Entry Boundary

At the facility's entry boundary the biological identity module acquires biological signals through a tiered acquisition strategy. The first tier is non-contact acquisition through gait analysis, facial dynamics observation, and behavioral pattern recognition as the individual approaches the entry point. If the non-contact acquisition produces insufficient confidence, the second tier applies intermediate semi-contact acquisition through handheld or body-proximate sensors. If the semi-contact acquisition does not achieve the required confidence level, the third tier applies high-assurance contact-based acquisition through dedicated sensors such as fingerprint, iris, or palm.

Each acquisition tier produces biological hashes that are evaluated against the individual's established trust-slope. The tiers are not mutually exclusive: the architecture fuses signals from multiple modalities and tiers, and the signal quality tier associated with each modality informs the confidence weighting applied during trust-slope construction, so the continuity assessment reflects the reliability of the signals from which it is derived.

Binding External Credentials to the Presenting Individual

The facility access scenario integrates the biological identity module with external credential verification. The module does not replace a presented credential; it binds the credential to the individual presenting it through behavioral continuity rather than through a single-point biometric scan. In the airport security checkpoint embodiment, passport verification confirms that the individual possesses a valid travel document, and biological trust-slope matching confirms that the individual presenting the passport is the same individual who has been continuously observed through the airport's non-contact monitoring infrastructure.

A passport that is passed from one individual to another fails the binding, because the biological trust-slope of the individual presenting the passport at the checkpoint is discontinuous with the trust-slope of the individual who was observed carrying the passport through the preceding concourse. The binding turns a document that any holder can present into a credential that is bound to a specific continuously observed individual.

Stress Anomaly Detection

The biological state inference capability of the biological identity module, the same capability applied to operator impairment detection in the vehicle and robotic domains, is applied to secure facility access as a stress anomaly detector. The module monitors the individual's physiological and behavioral signals for anomalies inconsistent with the individual's established baseline: elevated heart rate as inferred from remote photoplethysmography, altered gait dynamics suggesting heightened muscular tension, facial micro-expression patterns indicating concealed stress, and voice characteristics indicating elevated arousal when verbal interaction occurs.

Stress anomaly detection does not trigger automatic denial of access. It triggers graduated escalation through the confidence governor: mild anomalies produce elevated monitoring and additional verification questions; moderate anomalies trigger secondary screening; severe anomalies trigger security intervention. Anomaly is treated as a reason to escalate verification, not as a binary lockout.

Delegation and Multi-Person Authorized Access

The delegation mechanism disclosed in the biological identity chapter is applied to secure facility access to enable multi-person authorized access without sharing biological data. An authorized individual may delegate facility access to a designee without disclosing any component of the authorizing individual's biological identity chain. The delegation produces a cryptographically bound authorization token that links the designee's biological identity chain to the authorizing individual's access scope, subject to delegation constraints: temporal bounds limiting when the delegated access is valid, spatial bounds limiting which facility zones the delegated access permits, and capability bounds limiting what actions the delegated individual is authorized to perform.

The designee's biological identity is independently established through the same trust-slope continuity mechanisms. The delegation token confirms that the designee's access is authorized without revealing whose authority provides the authorization, so multi-person access is achieved without any individual disclosing or sharing biological data.

Capability Binding and Zone Authorization

The capability envelope system is applied to secure facility access as a capability binding mechanism in which the individual's resolved biological identity determines the set of facility zones, equipment, and information systems the individual is authorized to access. The capability binding is computed at each identity verification event: when the individual's biological identity is resolved with sufficient confidence, the system retrieves the individual's authorization profile and binds the authorized capabilities to the resolved identity.

The binding is temporal: it is valid only for a defined period and must be renewed through subsequent identity verification events. The binding is contextual: the authorized capabilities may vary based on time of day, facility operational status, and the individual's current access history. Authorization is therefore not a static grant attached to a card but a binding recomputed against the continuously validated identity.

Continuous Passive Monitoring

The access control system implements non-contact passive monitoring throughout the facility. Individuals who have been verified at the entry boundary are continuously monitored through non-contact modalities, gait analysis, behavioral pattern observation, and environmental sensing, as they move through the facility. The continuous monitoring maintains a running trust-slope continuity assessment that enables the system to detect identity substitution, where one individual replaces another after entry verification; tailgating, where an unverified individual follows a verified individual through a controlled boundary; and anomalous behavior, where a verified individual deviates from typical movement patterns within the facility.

When the continuous monitoring detects a discontinuity or anomaly, the system escalates from passive monitoring to active verification, requesting the individual to present at a verification point for contact-based or semi-contact-based re-verification. Verification is thus a continuous property of presence within the facility rather than a single event at the boundary.

Domain Separation and Privacy Posture

The biological hash is domain-scoped: it carries a domain separation tag that identifies the context within which the hash is generated, and a hash generated for one domain cannot be correlated with a hash generated for another domain even when both derive from the same underlying biological signal. An individual's facility access identity chain is therefore architecturally isolated from that same individual's identity chains in other domains such as financial services, social platforms, or healthcare.

The stable sketch from which each biological hash is generated is non-invertible by structural property of the architecture rather than by assumption about computational difficulty: dimensional reduction, many-to-one projection, and quantization each discard information that cannot be recovered. The system stores no template and no recoverable biological signal, so what an adversary could exfiltrate is a sequence of temporally bound non-invertible hashes, not a reusable key.

Disclosure Scope

The secure facility access application disclosed here comprises a system for secure facility access control with a tiered biological identity acquisition strategy progressing from non-contact through semi-contact to contact-based verification; stress anomaly detection through biological state inference with graduated escalation through the confidence governor; integration with external credential verification binding credentials to presenting individuals through behavioral continuity; delegation-based multi-person access without biological data disclosure; capability binding linking resolved identity to authorized zones and equipment; and continuous passive monitoring throughout the facility with escalation to active verification upon detection of identity substitution, tailgating, or anomalous behavior. The method comprises trust-slope continuity validation at facility boundaries, capability binding, and non-contact continuous monitoring with graduated anomaly response. This application is disclosed in the cognition filing (U.S. Application No. 19/647,395 and its international counterpart) at Section 13.7, drawing on the biological identity architecture of Chapter 9 and the capability envelope system of Chapter 6. This article describes that disclosed mechanism and does not extend beyond it.